A precision glass-and-steel device that delivers pharmaceutical-grade molecular iodine vapor directly into the airways — by breathing normally.
Iodine has been used clinically as an antiseptic for over 170 years. What has changed is the means of delivery. The Passive Molecular Iodine Inhaler draws pharmaceutical-grade PVPI solution through a precision chamber, liberating molecular iodine (I₂) vapor into each breath — quietly, continuously, and without aerosols or sprays.
Think of the clean, mineral-sharp air of the seashore. The effect here is similar in mechanism — iodine-laden air drawn naturally into the lungs — but deliberately controlled and precisely formulated.
The inhaler requires no electricity, no app, and no special technique. Breathe normally through the mouthpiece. The physics does the rest.
When you breathe through the Inhaler, the molecular iodine vapor is carried into the airways and lungs and, like other inhaled gases, is absorbed into the bloodstream — much as iodine-bearing air is absorbed when breathed at the seashore. The amounts involved are modest, carefully calibrated by the PVPI concentration of the refill solution.
Because the deliberate, repeated inhalation of iodine vapor has not been formally studied in humans in controlled clinical trials, we are transparent about this and recommend the cautions noted below.
Add your refill solution (1% PVPI pharmaceutical grade) to the glass reservoir to the marked fill line.
Replace the steel cap and mouthpiece. The sealed glass chamber preserves vapor concentration between sessions.
Breathe slowly and naturally through the mouthpiece for the recommended session duration — typically 3–5 minutes, 1–2 times daily.
Replace refill solution when the reservoir reads low or at the interval specified in your instructions. Each refill bottle supports multiple sessions.
Molecular iodine (I₂) is a small, lipophilic gas that behaves in the airways much as other inhaled gases do. Inhaled vapor is carried past the upper airway, into the bronchi, and ultimately into the alveoli — the deep lung surfaces where gas exchange occurs. There, as with oxygen and other inhaled gases, molecular iodine crosses the alveolar-capillary membrane and enters the systemic circulation.
This is not speculative. Iodine's absorption kinetics from inhalation have been documented in isotope-tracer and occupational-exposure research. What is borrowed from that literature is the mechanism: the vapor is retained and cleared from the respiratory tract with a half-time measured in minutes — consistent with rapid systemic absorption rather than local deposition alone.
"There are no systematic studies on health effects of inhalation of iodine vapor in humans."
— Ludwig et al., occupational exposure literature (frequently cited in iodine inhalation research)
We cite that statement not to alarm, but to be precise. The absorption pathway is well-characterized. The chronic safety of deliberate repeated inhalation at the doses this device delivers has not been the subject of a formal human clinical trial. We believe the analogy to iodine-rich sea air is apt and the amounts modest; we also believe honest transparency serves our customers better than overclaiming.
The iodine you take in via this device ultimately adds to your body's total iodine pool — a pool that, according to NHANES urinary iodine data, has declined substantially in the American population since the 1970s due to shifts in diet and agricultural practice.
This inhaler was not designed by marketers. It was built in direct response to a published clinical hypothesis by Dr. Raj K. Gandhi, a thoracic surgeon with more than fifty years of operative experience — including decades of applying povidone-iodine to cut pulmonary and pleural surfaces during surgery.
Dr. Gandhi's insight was straightforward: if surgeons have safely applied dilute PVPI directly to living lung tissue for generations, the question worth asking is whether molecular iodine vapor — inhaled through a very dilute solution — might travel through the airways and enter the systemic circulation in amounts sufficient to be biologically meaningful against respiratory pathogens.
In his 2021 paper in the Journal of Medical Research and Innovation, Dr. Gandhi laid out the biological rationale, estimated the dose range, and reported a brief personal self-experiment monitoring oxygen saturation and heart rate. He was careful to call what he had written what it is: a hypothesis we must test. He did not claim proof. He called for the human studies that would provide it.
We built this device to make his proposed therapy available for exploration — and to do so honestly. We name him, we cite his paper, and we use his own language: this is a clinically reasoned hypothesis, advanced by a surgeon of considerable standing, that merits investigation. Users of this inhaler are, in a meaningful sense, participants in that investigation.
Gandhi RK. J Med Res Innov. 2021;5(1):e000258. DOI: 10.32892/jmri.258 →
Ready to order the Inhaler
or request a refill?
$250 — Inhaler · $50 — Refills (10-pack) · One-year guarantee
Each inhaler is hand-assembled using borosilicate glass and surgical-grade steel. Refill solutions are pharmaceutical-grade PVPI prepared to specification.
Borosilicate glass reservoir, surgical steel housing, mouthpiece, instructions, and first refill solution included.
Pharmaceutical-grade 1% PVPI solution, prepared to specification. Ten refill bottles per package — each supports multiple sessions.
Iodine Products, Inc. was founded in South Miami, Florida by Eugene Rosov, whose work in iodine research and product development spans four decades. The company's mission is straightforward: to make pharmaceutical-grade iodine formulations accessible, affordable, and honestly explained — to everyone who needs them.
That mission grew from a conviction most of mainstream medicine has been slow to share: that the dramatic, documented decline in population iodine sufficiency since the 1970s — confirmed in the NHANES urinary iodine surveys — has had real, underappreciated consequences for human health. NHANES data show median urinary iodine levels have fallen by roughly 50% in American adults since 1971. Iodine does not merely support thyroid function; it is involved in immune signaling, breast tissue health, cognitive development, and mucosal defense.
The Passive Molecular Iodine Inhaler represents the newest and most technically demanding product in the Iodine Products line — designed to bring iodine directly to the lower respiratory tract by the most physiologically natural route available: breathing.
Our regulatory position is clear: none of our products are drugs. None make disease claims. They are devices and supplements offered to an adult public that deserves honest information and the freedom to make its own choices.
The lower respiratory tract is not sterile, and it is not immune to parasitic infection. Yet in the United States, the topic of pulmonary parasitology receives almost no attention in medical education — even among pulmonologists. Patients with chronic, unexplained respiratory symptoms are often cycled through courses of antibiotics, corticosteroids, and allergy workups without a single parasitic etiology considered.
This page is offered purely as an educational resource. It is not a diagnostic tool and does not imply that the Passive Molecular Iodine Inhaler treats, cures, or prevents any parasitic infection. If you suspect a parasitic lung infection, you need a physician — ideally one with infectious disease or tropical medicine training.
The organisms below represent the most clinically significant lower respiratory tract parasites with global or significant North American prevalence. They are worth knowing about.
Picture the same patient seen by two different physicians — a chronic cough that won't resolve, a throat that's always a little phlegmy, perhaps some wheeze. A pulmonologist practicing in much of Central or South America will, almost reflexively, keep parasitic infection somewhere on the list of possibilities, and may order a microscopic stool examination to rule it in or out. A pulmonologist practicing in the United States is vanishingly unlikely to think this way at all. The organisms are simply not on the mental map.
That difference is not about skill. It is about prior probability — what a physician expects to find based on where their patients live. And it leaves a real gap, because a meaningful number of people, wherever they live now, may carry organisms acquired elsewhere. When the possibility is never raised, parasitic disease in the lung is occasionally misread as something else entirely — including tuberculosis or malignancy.
Most of these infections begin in the gut or skin, not the lung. But several common ones travel through the lungs as part of their life cycle — entering the bloodstream, crossing lung tissue, climbing the airway, and being swallowed back down. During that passage they can cause cough, wheeze, asthma-like symptoms, or fleeting patches on a chest film. A smaller group can take up long-term residence and form chronic lesions — and those are the ones most often mistaken for other diseases.
Larvae travel through the liver and lungs before returning to the gut; symptoms may appear during that migratory phase.
Enters through the skin and passes through the lungs. In people with weakened immunity, it can cause far more serious, recurrent lung disease.
Follows a lung-migration pattern similar to Ascaris, with transient respiratory symptoms along the way.
Humans are accidental hosts; larvae wander through tissue, sometimes the lung, and can provoke eosinophilic inflammation.
A true lung fluke. Adults can live for years in lung tissue, producing cysts, scarring, and coughing of blood — with imaging that can closely resemble tuberculosis or a tumor.
Forms hydatid cysts that may sit in the lung for years, sometimes large enough to press on airways or rupture.
One note in the interest of accuracy: you may see Pneumocystis jirovecii listed alongside these. It is now classified as a fungus rather than a parasite. It lives in the air sacs and causes severe pneumonia, chiefly in people with significantly weakened immune systems. We mention it for completeness and to be precise about the distinction.
None of this means you have a parasite. Most coughs are ordinary, and most of these infections are intestinal rather than pulmonary. But the following pattern, taken together, is the kind of thing reasonable to raise with a physician — ideally one who keeps these possibilities in mind:
A chronic cough that hasn't resolved as expected · a persistently phlegmy throat or recurrent unexplained bronchitis · asthma-like symptoms without a clear cause · repeated or shifting patches on chest imaging, or pneumonia that won't fully clear · coughing up blood · an elevated eosinophil count on bloodwork · time spent in Central America, South America, or other regions where these infections are more common.
A complete family of pharmaceutical-grade iodine formulations — each with its own dedicated website, each developed over decades of research and clinical attention.
Oral and nasal PVPI spray for respiratory protection. Comprehensive information on COVID, cold, and flu prevention. Our most widely used product.
Visit Site → eyeodine.orgIodine-based ophthalmic products for red-eye, pink-eye, itching, mucus deposits, Demodex, and daily eye care. Multiple formulations.
Visit Site → superlugols.orgApproximately 500–600 doses of daily supplemental iodine per bottle. One bottle lasts over two years at $29. Pharmaceutical-grade Lugol's preparation.
Visit Site → iodinesoap.orgHighly effective iodine-enhanced soap for daily hygiene and pre-surgical preparation. Available in 2-, 5-, and 10-item lots.
Visit Site → fibrocystic.orgRoll-on iodine formulation for fibrocystic breast disease. Detailed clinical information on FBD, breast health, and iodine's documented role in breast tissue.
Visit Site → freeeyetest.orgFree Amsler Grid test for macular degeneration. Includes complimentary EyeOdine roll-on sample and free tape measure for vision monitoring.
Visit Site → churchofeden.orgFree supplemental iodine program for women of childbearing age. Available to those who certify need. A public health initiative.
Visit Site → pureplantsweet.orgAn extraordinary pure plant sweetener — internationally approved, healthy, safe, and delicious. One drop equals one teaspoon of sugar sweetness. 30 mL dropper bottle.
Visit Site → utopiaagency.netMedical malpractice resources for physicians. Includes a free patient-physician arbitration program designed to reduce adversarial litigation.
Visit Site → iodineproducts.comThe consolidated Shopify storefront linking all products at consistent pricing. One destination for the full product family.
Visit Store →All products: 305 667-9375 · erosov@iodineproducts.com